AsiaMedic Income Statement

Financials in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	35.22	28.91	23.6	18.88	18.26
Other Revenue	0.35	0.17	0.15	0.16	0.17
Revenue	35.57	29.09	23.75	19.04	18.42
Revenue Growth (YoY)	22.29%	22.46%	24.72%	3.38%	19.81%
Cost of Revenue	25.89	23.28	18.4	14.78	14.25
Gross Profit	9.68	5.8	5.35	4.27	4.17
Selling, General & Admin	1.48	0.12	0.11	0.14	0.14
Other Operating Expenses	3.87	2.56	2.45	2.15	1.97
Operating Expenses	8.73	5.16	4.63	3.34	3.38
Operating Income	0.94	0.65	0.72	0.92	0.79
Interest Expense	-0.91	-0.59	-0.42	-0.24	-0.15
Interest & Investment Income	0.11	0.17	0.17	0.04	0.02
Earnings From Equity Investments	-0.63	0.32	0.44	0.48	0.36
Other Non Operating Income (Expenses)	0	0.02	-	-	0.09
EBT Excluding Unusual Items	-0.48	0.57	0.91	1.21	1.12
Impairment of Goodwill	-	-0.05	-	-0.52	-
Gain (Loss) on Sale of Assets	1.91	-	-	-	-
Asset Writedown	-	0.12	0.12	1.5	-0.86
Other Unusual Items	-	-	-	-	0.45
Pretax Income	1.43	0.64	1.03	2.19	0.72
Income Tax Expense	-	-0	-0.89	-	-
Earnings From Continuing Operations	1.43	0.65	1.92	2.19	0.72
Minority Interest in Earnings	0.59	0.36	-	-	-
Net Income	2.02	1.01	1.92	2.19	0.72
Net Income to Common	2.02	1.01	1.92	2.19	0.72
Net Income Growth	100.45%	-47.44%	-12.13%	205.72%	-
Shares Outstanding (Basic)	1,140	1,155	1,132	1,120	1,120
Shares Outstanding (Diluted)	1,140	1,155	1,132	1,120	1,120
Shares Change (YoY)	-1.22%	1.97%	1.13%	-	2.36%
EPS (Basic)	0.00	0.00	0.00	0.00	0.00
EPS (Diluted)	0.00	0.00	0.00	0.00	0.00
EPS Growth	104.14%	-48.76%	-13.11%	225.88%	-
Free Cash Flow	1.2	0.68	0.98	0.23	3.06
Free Cash Flow Per Share	0.00	0.00	0.00	-	0.00
Gross Margin	27.20%	19.95%	22.52%	22.40%	22.65%
Operating Margin	2.65%	2.22%	3.03%	4.85%	4.31%
Profit Margin	5.69%	3.47%	8.09%	11.48%	3.88%
Free Cash Flow Margin	3.38%	2.32%	4.14%	1.23%	16.60%
EBITDA	1.84	1.34	1.6	1.19	1.17
EBITDA Margin	5.17%	4.59%	6.74%	6.24%	6.35%
D&A For EBITDA	0.89	0.69	0.88	0.27	0.38
EBIT	0.94	0.65	0.72	0.92	0.79
EBIT Margin	2.65%	2.22%	3.03%	4.85%	4.31%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.